Tumor-infiltrating CD4+, CD8+ T cells, and NK cells in patients with HCC have been found to be functionally compromised, and the low CD4+ and CD8+ TIL counts have been found to predict extremely poor HCC-specific survival17. This evidence concerns the gene CD8A and neoplasm.